Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GAO vets DMEPOS oversight

This article was originally published in The Gray Sheet

Executive Summary

A 1Sept. 22 report from the Government Accountability Office finds that efforts by a CMS contractor are insufficient to prevent Medicare fraud by medical equipment suppliers. Licensure checks by the contractor, National Supplier Clearinghouse, are ineffective because they rely on "self-reported information about the items suppliers intend to provide to beneficiaries and [do] not match this against actual billing later," GAO writes. In addition, NSC overlooks too many suppliers in its on-site inspection program. GAO urges CMS to strengthen its supervision of the NSC anti-fraud program, which affects suppliers of durable medical equipment, prosthetics, orthotics and other supplies...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022775

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel